Diazepam in the treatment of organophosphorus ester pesticide poisoning

Toxicological Reviews

Volumn 22, Issue 2, 2003, Pages 75-81

  Marrs, Timothy C ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; ANTICONVULSIVE AGENT; ANTIDOTE; ARMIN; ATROPINE; BENZODIAZEPINE; DIAZEPAM; DRUG METABOLITE; DYFLOS; FENITROTHION; HYPNOTIC SEDATIVE AGENT; NORDAZEPAM; OBIDOXIME; ORGANOPHOSPHATE PESTICIDE; OXIME; PARAOXON; PHENAZOPYRIDINE; QUINALPHOS;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONVULSION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INCOMPATIBILITY; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; FASCICULATION; HUMAN; INTOXICATION; LETHALITY; MUSCLE RELAXATION; NONHUMAN; OUTCOMES RESEARCH; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT;

ANIMALS; ANTIDOTES; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA MODULATORS; HUMANS; INJECTIONS, INTRAVENOUS; INSECTICIDES; ORGANOPHOSPHORUS COMPOUNDS; POISONING;

ANIMALIA;

EID: 1642567469     PISSN: 11762551     EISSN: None     Source Type: Journal    
DOI: 10.2165/00139709-200322020-00002     Document Type: Review

References (57)

1. Charney DS, Mihic SJ, Harris RA. Hypnotics and sedatives. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman & Gilman's: The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001, 427
2. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: Psychosis and anxiety. In: Hardman JG, Limbird LE, Molinoff PB. et al., editors. Goodman & Gilman's: The pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996, 399
3. Pieri L, Schaffner R, Scherschlicht R, et al. Pharmacology of midazolam. Arzneimittelforschung 1981: 31: 2180-201
4. Sellström A. Anticonvulsants in anticholinesterase poisoning. In: Ballantyne B, Marrs TC. Clinical and experimental toxicology of organophosphates and carbamates. Oxford: Butterworths, 1992: 578-86
5. Diamantis W, Kletzkin M. Evaluation of muscle relaxant drugs by head-drop and by decerebrate rigidity. Int J Neuropharmacol 1966: 5: 305-10
6. Allison C, Pratt JA. Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther 2003; 98: 171-95
7. A receptor pharmacology. Pharmacol Ther 1996; 69: 173-98
8. A receptor subtypes. Curr Top Med Chem 2002; 2: 795-816
9. Ortells MO, Lunt GG. Evolutionary history of the ligand-gated ion-channel super-family of receptors. Trends Neurosci 1995; 18: 121-7
10. Costa E, Guidotti A. Molecular mechanisms in the receptor action of benzodiazepines. Ann Rev Pharmacol Toxicol 1979; 19: 531-45
11. Tonkopii VD, Sofronov GA, Aleksandriiskaya IE, et al. Mechanism of the effect of diazepam on acetylcholine concentration in mouse brain [in Russian]. Bull Exp Biol Med 1978: 86: 38-40
12. Flynn CJ, Wecker L. Elevated choline levels in brain: A non-cholinergic component of organophosphate toxicity. Biochem Pharmacol 1986; 35: 3115-21
13. Lundgren G, Nordgren I, Karlen B, et al. Effects of diazepam on blood choline and acetylcholine turnover in brain of mice. Pharmacol Toxicol 1987; 60: 96-9
14. Lundy PM, Magor GF. Cyclic GMP concentrations in cerebellum following organophosphate administration. J Pharm Pharmacol 1978; 30: 251-2
15. Bosković B. The treatment of soman poisoning and its perspectives. Fundam Appl Toxicol 1981; 1: 203-13
16. Mandelli M, Tognoni G, Garattini S. Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 1978; 3: 72-91
17. Hillestad L, Hansen T, Melsom H, et al. Diazepam metabolism in normal man. 1: Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration. Clin Pharmacol Ther 1974; 16: 479-84
18. Klotz U, Antonin KH, Bieck PR. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J Pharmacol Exp Ther 1976; 199: 67-73
19. Viani A, Rizzo G, Carrai M, et al. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. Br J Clin Pharmacol 1992; 33: 299-304
20. Kanto J, Kangas L, Siirtola T. Cerebrospinal-fluid concentration of diazepam and its metabolites in man. Acta Pharmacol Toxicol 1975; 36: 328-34
21. Klotz U, Antonin KH, Bieck PR. Comparison of the pharmacokinetics of diazepam after single and subchronic doses. Eur J Clin Pharmacol 1976; 10: 121-6
22. Morselli PL, Cassano GF, Placidi GF, et al. Kinetics of the distribution of 14C-diazepam and its metabolites in various areas of cat brain. In: Garattini S, Mussini E, Randall LO. The benzodiazepines. New York: Raven Press, 1974, 70
23. Klotz U, Avant GR, Hoyumpa A, et al. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 1975; 55: 347-59
24. Andreasen PB, Hendel J, Greisen G, et al. Pharmacokinetics of diazepam in disordered liver function. Eur J Clin Pharmacol 1976; 10: 115-20
25. Hvidberg EF, Dam M. Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokinet 1976; 1: 161-88
26. Booker HE, Celesia GG. Serum concentrations of diazepam in subjects with epilepsy. Arch Neurol 1973; 29: 191-4
27. Lundy PM, Magor G, Shaw RK. Gamma aminobutyric acid metabolism in different areas of rat brain at the onset of soman-induced convulsions. Arch Int Pharmacodynam 1978; 234: 64-73
28. Churchill L, Pazdernik TL, Cross RS, et al. Cholinergic systems influence local cerebral glucose use in specific anatomical areas: Diisopropyl phosphorofluoridate versus soman. Neuroscience 1987; 20: 329-39
29. Rump S. Grudzinska E. Investigations on the effects of diazepam in acute experimental intoxication with fluostigmine. Arch Toxicol 1974; 31: 223-32
30. Kleinrok Z, Jagiello-Wojtowicz E. The influence of some anticonvulsant drugs on the acute toxicty of disopropylfluorophosphate in mice [in Polish]. Ann Univ Mariae Curie Sklodowska 1977; 32: 155-60
31. Krutak-Krol H, Domino EF. Comparative effects of diazepam and midazolam on paraoxon toxicity in rats. Toxicol Appl Pharmacol 1985; 81: 545-50
32. Doebler JA, Wall TJ, Martin LJ, et al. Effects of diazepam on soman-induced brain neuronal RNA depletion and lethality in rats. Life Sci 1985; 36: 1107-15
33. Matsubara T, Horikoshi I. Possible antidotes in severe intoxication with fenitrothion in rats. J Pharmacobio Dynam 1983; 6: 699-707
34. Johnson DD, Wilcox WC. Studies on the mechanism of the protective and antidotal actions of diazepam in organophosphate poisoning. Eur J Pharmacol 1975: 34: 127-32
35. Johnson DD, Lowndes HE. Reduction by diazepam of repetitive electrical activity and toxicity resulting from soman. Eur J Pharmacol 1974; 28: 245-50
36. Martin LJ, Doebler JA, Shih T-M, et al. Protective effect of diazepam pretreatment on soman-induced brain lesion formation. Brain Res 1985: 325: 287-9
37. Kassa J, Bajgar J. Treatment of the stressogenic effect of dichlorvos. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 1994; 37: 29-32
38. Gupta RC. Acute malathion toxicosis and related enzymatic alterations in Bubalus bubalis: Antidotal treatment with atropine, 2-PAM, and diazepam. J Toxicol Environ Health 1984; 14: 291-303
39. Lipp A. Effect of diazepam upon soman-induced seizure activity and convulsions. Electroencephalogr Clin Neurophysiol 1972; 32: 557-60
40. Lipp JA. Eltect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch Int Pharmacodynam Ther 1973; 202: 244-51
41. Inns RH, Leadbeater L. The efficacy of hispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig. J Pharm Pharmacol 1983; 35: 427-33
42. Bokonjić D, Jovanović D, Jokanović M, et al. Protective effects of oximes HI-6 and PAM-2 applied by osmotic minipumps in quinalphos-poisoned rats. Arch Int Pharmacodynam Ther 1987; 288: 309-18
43. Rump S, Faff J, Szymanska T, et al. Efficacy of repeated pharmacotherapy in experimental acute poisonings with fluostigmine. Arch Toxicol 1976; 35: 275-80
44. Yacoub M, Skouri H, Amamou M, et al. Intoxications aiguës par les insecticides organo-phosphorés: A propos de 908 cas observés au Centre Anti-Poisons de Tunis. J Toxicol Med 1981; 1: 165-88
45. Kusič R, Jovanović D, Randjelović S, et al. HI-6 in man: Efficacy of the oxime in poisoning by organophosphorus insecticides. Hum Exper Toxicol 1991; 10: 113-8
46. Weissmann-Brenner A, David A, Vidan A, et al. Organophosphate poisoning: A multihospital survey. Israel Med Assoc J 2002; 4: 573-6
47. Karalliedde L, Szinicz L. Management of organophosphorus compound poisoning, In: Karalliedde L, Feldman S, Henry J, et al. Organophosphates and health. London: Imperial College Press, 2001, 257-94
48. Rolfsfjord LB, Fjaerli HO, Meidel N, et al. Severe organophosphate (demeton-S-methyl) poisoning in a two-year-old child. Vet Hum Toxicol 1998; 40: 222-4
49. Marti J, Reverté C, Roig M, et al. Uso del diacepam en la intoxicación por insecticidas organofosforados. Ann Esp Pediatr 1985; 23: 299-301
50. LeBlanc FN, Benson BE, Gilg AD. A severe organophosphate poisoning requiring the use of an atropine drip. J Toxicol Clin Toxicol 1986; 24: 69-76
51. de Kort WLAM, Kiestra SH, Sangster B. The use of atropine and oximes in organophosphate intoxications: A modified approach. J Toxicol Clin Toxicol 1988; 26: 199-208
52. Barckow D, Neuhaus G, Erdmann WD. Zur Behandlung der schweren Parathion-(E605(R))-Vergiftung mit dem Cholinesterase-Reaktivator Obidoxim (Toxogonin®). Arch Toxicol 1969; 24: 133-46
53. Vale JA, Scott GW. Organophosphorus poisoning. Guy's Hosp Rep 1974; 123: 13-25
54. Jovanović D, Randjelovic S, Joksovic D. A case of unusual suicidal poisoning by the organophosphorus insecticide dimethoate. Hum Exper Toxicol 1990; 9: 49-51
55. Merrill DG, Mihm FG. Prolonged toxicity of organophosphate poisoning. Crit Care Med 1982; 10: 550-1
56. Johnson MK, Vale JA. Clinical management of acute organophosphate poisoning: An overview. In: Ballantyne B, Marrs TC. Clinical and experimental toxicology of organophosphates and carbamates. Oxford: Butterworth Heineman, 1992, 35
57. McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994; 8: 461-75